Today is: Sunday, September 07, 2008 Neotrope®
Press Release Writing and News Distribution
Affordable Newswire Services and Targeted Distribution
Send2Press® - Press Release Writing, Targeted News Distribution and Media Relations since 1983 press release writing and distribution services from send2press
Newswire Services Press Release Writing Order Send2Press Services
Affordable Newswire Services and Targeted Distribution
BUSINESS WEB WIRE PR NEWSWIRE SERVICES
Press Release Distribution
PR Services
 Search:     
  Translate Page:  
 

U.S. and World News : Medical : Drugs and Pharmaceuticals News

Ionic Silver Complex Designed for Use in Humans Receives U.S. Patent

Tue, 29 Nov 2005, 12:09:00 EDT
Edited by Christopher Simmons Email this article Print this news article Share Content  Contact This Company


May Render Colloidal Silver and other Nano Silver Technologies Obsolete

FORT LAUDERDALE, FL (SEND2PRESS NEWSWIRE) -- Invision International Health Solutions, Inc., a pioneer in the field of ionic silver use in humans, recently announced the issuance of a U.S. Patent on its "Ionic Silver Complex" technology.

The technology is also patented in Australia and New Zealand, and patents are pending in Europe and Japan. The patents provide broad composition-of-matter protection, covering a wide range of complexing agents and counter-ions.

The use of ionic silver in human use goes back hundreds -- indeed thousands -- of years. During the past century, it was predominantly used in the medical field in the forms of silver nitrate and colloidal silver -- which has been increasingly used during the past few decades. In Europe, pharmacists have silver compounds listed in their desk references for many uses. In the U.S., recent university studies are suggesting far-reaching potential benefits of ionic silver. The past few years have seen a surge in the number of medical and industrial products that deliver silver ions, for a wide range of uses.

Whether colloidal silver, silver-impregnated bandages and wound dressings, coatings for surfaces in hospitals and homes, or catheters and IV needles, the goal is the controlled delivery of silver as ions. Delivery is a function of the bonding agent - the complexing or compounding agent - which controls the release of the silver as ions in the given environment at the desired rate.

Invision has already incorporated the patented technology into a water-based dietary supplement called Silver 100. The key ingredient in Silver 100 is called Opti-Silver - silver ions complexed with citrate and potassium for optimal delivery of silver ions in the human body.

According to Jay Newman, president of Invision International, the patented technology represents a quantum leap in delivering silver ions internally to the human body. "We chose citrate because we believe it is, by far, the ideal carrier for efficient delivery of silver ions for human use," Newman said, "based on years of effort and research that required millions of dollars invested." Potassium is used as the counter-ion for equilibrium in the water. "Silver 100 uses all-natural ingredients and is intended to provide an entirely safe product that introduces less silver to the body than what may exist in a person's average drinking water intake - but as active ions."

"We believe the compounds in colloidal silver have bonds that are too strong and thus release only a small percentage of their silver as ions in the body," Newman said, "while products called 'ionic' or 'nano' are usually just colloidal silver -- or are common substances like silver nitrate thrown in water and, as such, the bonds are far too weak to carry the silver ions into the body. Colloidal silver is manufactured through a crude, antiquated process called electrolysis. Many companies promote colloidal silver -- and 'ionic' and 'nano' silver -- using flamboyant marketing claims about particle size, parts per million, and safety that have little if any basis in scientific fact. We are bringing legitimacy and integrity to the field."

"'Nano silver' is the sexy new term for ionic silver," Newman said, "yet the imperative for an efficient delivery mechanism for human use is still the bottom line. Opti-Silver is nano silver with real science behind it to achieve that imperative. Having begun our intensive R&D efforts about ten years ago, we believe we are positioned at the leading edge of a large market that is just beginning to develop."

Silver 100 is sold primarily in health food stores at present, mainly in the eastern U.S., including some regions of Whole Foods. It is carried by United Natural Foods, the country's largest health foods distributor. Invision is rolling out national marketing and expects the product to be in the majority of health food stores, as well as supermarkets and pharmacies, by 2007.

For further information see www.silver100.com or contact the company at info@silver100.com. The U.S. Patent can be seen on the web site of the U.S. Patent & Trademark Office by going to http://www.silver100.com/USPatent.html.


About the Company

Invision International Health Solutions, Inc., a privately held company based in Fort Lauderdale, Florida, specializes in the research and development of ionic silver delivery solutions for human use. Because the patent covers a broad range of potential formulations, the company intends to pursue rigorous clinical studies, and FDA dietary supplement "health claims" approval as well as drug approval, for certain embodiments of the current patented technology and future technologies.

Jay Newman, the company's founder and President, has been interviewed as the industry expert on Good Morning America, NBC TV News, the Mining Industry Review, Wired News, and dozens of radio shows. He is a co-founding member of the Committee for the Responsible Use of Silver in Health, which is hosted at http://www.silverfacts.com. He is a co-inventor on the patent.


Disclaimer

No studies have been conducted to either prove or disprove whether the patented technology delivers silver ions to the human body in a way that benefits the body. The statements herein have not been evaluated by the Food & Drug Administration. No product covered under the patent, or information thereon, is intended to diagnose, treat, cure or prevent any disease.


Silver 100 and Opti-Silver are trademarks of Invision International


  NEWS SOURCE:  Invision International Health Solutions, Inc.
 Send2Press® is the originating wire service for this story.

» Read More Drugs and Pharmaceuticals News
» Other Send2Press Industry News by Category

More Information and Media Contact:
For questions about this story, contact the news source:
» Click Here for Contact Information
THE CONTENT OF THE ABOVE NEWS STORY WAS PROVIDED BY THE NEWS SOURCE WHO IS SOLELY RESPONSIBLE FOR ITS ACCURACY. FOR QUESTIONS ABOUT THIS STORY CONTACT THE NEWS SOURCE AND NOT SEND2PRESS (THIS WEBSITE).

R E A D E R   R E S O U R C E S
» E-mail This Article    » Printer-Friendly Version
» Choose RSS News Feeds by Topic
 Subscribe in a reader
Add News to Google   Add News to My Yahoo!   Add News to MyMSN   Add to My Wikio

Bookmark and/or share this content with your social network:
del.icio.us:Ionic Silver Complex Designed for Use in Humans Receives U.S. Patent  digg:Ionic Silver Complex Designed for Use in Humans Receives U.S. Patent  blinklist:Ionic Silver Complex Designed for Use in Humans Receives U.S. Patent  furl:Ionic Silver Complex Designed for Use in Humans Receives U.S. Patent  blogmarks:Ionic Silver Complex Designed for Use in Humans Receives U.S. Patent  reddit:Ionic Silver Complex Designed for Use in Humans Receives U.S. Patent  Y!:Ionic Silver Complex Designed for Use in Humans Receives U.S. Patent
Add to Mixx!

» Permalink for This Article
[ http://www.send2press.com/newswire/2005-11-1129-002.shtml ]


ADDITIONAL NEWS FROM
Invision International Health Solutions, Inc.

» Ionic Silver Complex Designed for Use in Humans Receives U.S. Patent

» Ionic Silver Complex Designed for Antimicrobial Use in Humans Receives U.S. Patent

» More Drugs and Pharmaceuticals News  » Top of Page  » Home

J O U R N A L I S T   R E S O U R C E S

Media Copy of Original Press Release:
Plain Text Copy of News Article  PLAIN TEXT FORMAT (UTF-8)      PDF Text Copy of News Article  PDF FORMAT

» Weekly E-Mail News Summary    » RSS Feeds by Topic
» Add Our Headlines to Your Site Automatically (FREE)

Find More News Content About
Invision International Health Solutions, Inc.

 Site Search:     


O T H E R   R E S O U R C E S
Business Tools:
» Send Your News to the Media
» Targeted News Distribution
» Press Release Writing and Editing
Webmaster Tools:
» Add Our Headlines to Your Website

 
T E R M S   O F   U S E
This article is Copr. © 1983-2008 Neotrope / Send2Press. Reproduction of this news article version requires written authorization. You may freely link to this article. Journalists (see the section "Journalist Resources" above) may use orig. news release as the basis for an article. News Websites may republish the "news release" text version linked to above under "Journalist Resources" except must retain "Send2Press Newswire" as the source of this news if used verbatim. Websites which offer/sell PR or newswire services, or web promotion services, or "splogs" may NOT reprint our content in ANY form. Send2Press Newswire is a service mark of, and "Send2Press" is a registered trademark of, Neotrope. Creative Commons - Some Rights Reserved (3.0) - Attribution Required.

DISCLAIMER: the above article is believed accurate but not guaranteed, and is based on business news supplied by the source (Invision International Health Solutions, Inc.). The noted source is solely responsible for its accuracy. Financial/Stock news may contain forward looking statements. Neotrope/Send2Press makes no claims of accuracy or suitability for any purpose. Any opinions expressed by representatives of company(s) mentioned in news and profiles are solely those of the person indicated, and do not reflect any opinion or policy of Neotrope or Send2Press. Your use of any information contained herein is done solely at your own risk, and you are fully responsible for using any information herein, or on sites mentioned or linked to in the article. All trademarks acknowledged.

REFERENCES: .
VIEWED BY MEDIA (and public): 7413 times (5 today, 5 this week, 28 this month, 1055 this year)

Drugs and Pharmaceuticals
Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for The Treatment of Osteosarcoma
Phase I/II Study of Targeted Gene Delivery In Vivo - Intravenous Infusions of REXIN-G
CYNACON / OCuSOFT(R) Announces OCuSOFT(R) Lid Scrub(TM) PLUS Now Available in CVS Pharmacies
Targeted Gene Delivery Signals Cancer Vaccination in Vivo
TARGETED GENE DELIVERY IN VIVO: Rexin-G Monotherapy Reveals Significant Biological Activity without Toxicity in Chemo-Resistant Metastatic Breast Cancer (ASCO 2008)
ASCO 2008: Tumor-Targeted Rexin-G Demonstrates Dose-Dependent Anti-Tumor Activity without Toxicity in Metastatic Pancreatic Cancer
Eularis to Address Marketing Return at Japanese Pharmaceutical Marketing Excellence Conference
Eularis to Address Making the Right Research Decision for ROI
Interim Analysis of Phase I/II Study of Rexin-G Confirms Efficacy with No Dose Limiting Toxicity in Metastatic Pancreatic Cancer
Cypress Systems, Inc. Launches Cancer Prevention Health Campaign Using SelenoExcell(R)
Mark Whitacre, Ph.D. Promoted at Cypress Systems, Inc. and a Warner Bros. Movie to be Filmed About Him
Epeius Biotechnologies Awarded U.S. Patent for Targeted Injectable Gene Delivery In Vivo
Eularis Exposes Hidden Barriers to Patient Adherence with New Pharmaceutical Industry Report
MEDIA ALERT: Eularis to Address Marketing Return at Measuring Marketing ROI in Pharma Conference in London
Losing Weight But Still Have Belly Bulge?
Myo-Med, Tom Brady and STG Media Corp. Team Up to Jump Start Myo-Med's 2008 Advertising Campaign
Recent Studies Suggest Popular 'Diet Pill' Reduces Acne Breakouts
deverus, Inc. Partners with eScreen Inc. to Offer First and Only Instrumented Instant Drug Testing Device to Clients
Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine
ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G, a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
New Report Examines Pharmaceutical Sales Force Effectiveness
FDA Approves the Opening of a Phase II Registration Protocol Using REXIN-G(R) for Osteosarcoma in California U.S.A.
OCuSOFT Refutes Comparison Time-Kill Study Released by Advanced Vision Research
Ophthalmic Research and Development Company Launches Adjunctive Eyelid Therapy and Hygiene Product
U.S. Pharmaceuticals Spend $8 Billion Annually in R&D Conducted Overseas - New Clintelligence(R) Alignment Module Advances Global Management

» View All News Channels
» Press Release Services
» Send2Press Home Page

U.S. and World News
STG Media Corp. Helps Resolve the Health Issues Associated with Tobacco
Card Cafe Promotes Kira Case to Vice President and General Manager
WhiteFlash.com Pushes Youth 'AWEARness' at Teen Choice 2008
Bob Taylor Achieves Accreditation as a Certified Digital Marketing Consultant (CDMC)
Cognitive Technologies Receives Microsoft Federal Partner Award
Top Haunted Attractions Select INTERACTIVE TICKETING for Online Sales
Major Unofficial Upgrade for Microsoft(R) Windows(R) Vista and XP Released by Extensoft
Arclinea San Diego Wins Two National Design Awards
Home Shopping Latino, Inc. Launches a $6 Million Dollar Global Media Fund Campaign
iSkin's New solo for iPhone 3G Delivers Slim-fitting Protection for a High-Gloss Fashion Makeover
Kathleen Gilmartin Joins Interim HealthCare Inc. as New President and CEO
Georgia Department of Education Launches HOSA Foundation to Promote Careers in Healthcare
Van Millwork Presents Fall 2008 Home Design Series - Informative Seminars for New England Homeowners
Allegro Gets Traction with Direct Marketing Blog
Napco Asset Management and Packman Financial Finalize Merger
Blues Band Aunt Kizzy'z Boyz Beats Out Youthful Competition to Win LAMN Jam Finale by a Landslide
LTC Financial Partners (LTCFP) is Fastest-Growing Long Term Care Insurance Specialist on Inc. Magazine List
LocaModa Interactive Social Media Platform Used to Inspire Public Policy Debates at Both DNC and RNC
Southwest Ohio's First and Largest Outpatient Pain Clinic Continues to Grow Despite Weak Economy
Worldwide Mobile Content Tools Market to Top $8 Billion in 2008, says INSIGHT Research Corp.
Savannah Economic Development Authority brings Savannah to Atlanta Sept. 2
exxHelp Help Doc Builder Software Released
AP Financial, Inc. Opens Another Office in San Diego, California
Libera Acquires Pintexx
Country Swing Makes a Comeback on New Song from Joss and Colosio

» View All News Channels
» Press Release Services
» Send2Press Home Page
Full Text RSS 2.0 news feed RSS 0.91 Summary News Feed Entertainment Podcast RSS Feed
» View Menu of News Feeds by Topic
— ADVERTISEMENT —
Promote Your Company to the Media
and on This Website

Press release services from Neotrope®. Member BBB. Expert PR staff. Targeted solutions since 1983. Learn More
Business News 
 
 U.S. and World News
 Advertising and Marketing
 Aerospace and Aviation
 Agriculture and Farming
 Auction and Online Auctions
 Auto and Motorsports
 Banking and Finance
 Beauty Products
 Boating, Marine and Maritime
 Business
 Communication Arts
 Computing
 Construction and Building
 Corporate Social Responsibility - CSR
 Defense and Military
 Education and Schools
 Electronics
 Employment, HR and Outsourcing
 Energy, Oil and Gas
 Entertainment
 Environment and Ecology
 Facilities and Building Maintenance
 Family, Parenting and Children
 Firearms and Airguns
 Food and Beverages
 General Editorial
 Global Aid and Relief
 Government
 Green Business
 Health, Diet and Fitness
 Home and Garden
 HVAC Heating and Cooling
 Insurance
 Internet and Websites
 Jewelry and Diamond
 Legal and Law
 Manufacturing
 Medical
 Alternative Medicine 
 Biotechnology 
 Cosmetic Surgery 
 Dentistry 
 Devices and Research 
 Disabilities and 508 Compliance 
 Drug Rehabilitation 
 Drugs and Pharmaceuticals 
 Fertility and IVF 
 Hospitals and Nursing 
 Long Term Care 
 Medical and Health Products 
 Medical Business Services 
 Private Practice and Medical Groups 
 Surgery and Neurotechnology 
 Mining and Metals
 NonProfit and Charities
 Plastics and Composites
 Police, Fire and Rescue
 Real Estate
 Regional Events
 Religion and Churches
 Restaurant, Hotel and Hospitality
 Safety and Security Solutions
 Sciences
 Sports and Activities
 Stamps, Coins and Collectables
 Taxes and Accounting
 Telecommunications and VoIP
 Theme Parks and Attractions
 Trade Shows, Fairs and Expos
 Transportation
 Travel and Tourism
 U.S. Companies
 US and World History
 Veterinary and Pets
 
 U.S. State Newswires
 Alabama Business
 Alaska Business
 Arizona Business
 California Business
 Colorado Business
 Connecticut Business
 Florida Business
 Georgia Business
 Hawaii Business
 Idaho Business
 Illinois Business
 Iowa Business
 Kansas Business
 Maryland Business
 Massachusetts Business
 Michigan Business
 Minnesota Business
 Mississippi Business
 Missouri Business
 Nebraska Business
 Nevada Business
 New Jersey Business
 New Mexico Business
 New York Business
 North Carolina Business
 Ohio Business
 Oklahoma Business
 Oregon Business
 Pennsylvania Business
 Puerto Rico Business
 South Carolina Business
 South Dakota Business
 Tennessee Business
 Texas Business
 Utah Business
 Vermont Business
 Virginia Business
 Washington D.C. Business
 Washington State Business
 West Virginia Business
 Wisconsin Business
 
 Video News Releases
 
 World Newswires
 Brazil Business
 Canada Business
 Germany Business
 Spain Business
 United Kingdom

Subscribe to FREE
Send2Press®
Weekly News Alert

» Privacy Statement
» How to Unsubscribe

Click to Hear Podcasts
» Click to Hear Podcasts

Recent Send2Press News Network Placements on:
newswire placement on Google News
Advertising Industry
FURL LookSmart Publishers Newswire
Yahoo! News
Technorati News

INTERNET NEWSWIRE ARCHIVE SPONSORS
Website Promotion Services and SEO PR
Powered by Neotrope®
» View a list of our news archive sponsors
Learn about Send2Press Media Solutions

Florida Business News is Powered by Florida Newswire™
Technorati Tags: